CALR and JAK2 mutations represent 2 disease spectrums in essential thrombocythemia whereby cases with mutated CALR are characterized by higher platelet levels, lower hemoglobin and leukocyte counts, and lower thrombosis risk compared with JAK2-mutated patients. Professional illustration by Debra T. Dartez.